NPI: 1316906928 · ASHEVILLE, NC 28805 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,679 | $283K |
| 2019 | 27,133 | $316K |
| 2020 | 22,411 | $370K |
| 2021 | 20,337 | $291K |
| 2022 | 14,160 | $308K |
| 2023 | 4,816 | $182K |
| 2024 | 3,260 | $232K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 48,978 | 3,848 | $1.71M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,343 | 2,091 | $198K |
| J1756 | Injection, iron sucrose, 1 mg | 6,656 | 1,741 | $30K |
| J1270 | Injection, doxercalciferol, 1 mcg | 21,679 | 1,961 | $29K |
| A4657 | Syringe, with or without needle, each | 2,165 | 1,872 | $12K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 24 | 12 | $210.60 |
| 83540 | 1,481 | 1,445 | $0.00 | |
| 83970 | 730 | 698 | $0.00 | |
| 85041 | 1,308 | 1,279 | $0.00 | |
| 85048 | 1,296 | 1,267 | $0.00 | |
| 83550 | 1,471 | 1,436 | $0.00 | |
| 82728 | 1,486 | 1,454 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 110 | 85 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 42 | 41 | $0.00 |
| 90674 | 27 | 26 | $0.00 |